BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 37593813)

  • 21. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
    Rosendahl M; Høgdall CK; Mosgaard BJ
    Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?
    Jaishankar S; Pifer PM; Bhargava R; Keller A; Musunuru HB; Patel AK; Sukumvanich P; Boisen M; Berger JL; Taylor S; Courtney-Brooks M; Olawaiye A; Lesnock J; Edwards R; Vargo JA; Beriwal S
    Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):452-458. PubMed ID: 35264314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A suggested modification to FIGO stage I endometrial cancer.
    Aristizabal P; Graesslin O; Barranger E; Clavel-Chapelon F; Haddad B; Luton D; Darai E; Rouzier R; Koskas M
    Gynecol Oncol; 2014 May; 133(2):192-6. PubMed ID: 24631453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
    Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
    Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
    Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan.
    Lee YY; Lai YL; Kim MS; Chang K; Kim HS; Cheng WF; Chen YL
    J Gynecol Oncol; 2024 May; 35(3):e33. PubMed ID: 38130137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The struggle against endometrial cancer: ten years of experience of a tertiary center.
    Bilgi A; Guler AH; Kulhan M; Cintesun E; Ates M; Celik C
    Ginekol Pol; 2022; 93(5):351-360. PubMed ID: 34155618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathologic Staging of Endometrial Carcinomas: Selected Areas of Difficulty.
    McCluggage WG
    Adv Anat Pathol; 2018 Mar; 25(2):71-84. PubMed ID: 29356713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic performance of the 2023 FIGO staging schema for endometrial cancer.
    Matsuo K; Chen L; Klar M; Lee MW; Machida H; Mikami M; Muderspach LI; Carlson JW; Roman LD; Wright JD
    Gynecol Oncol; 2024 May; 187():37-45. PubMed ID: 38713997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evaluation of reliability and contribution of frozen section pathology to staging endometrioid adenocarcinomas.
    Karabagli P; Ugras S; Yilmaz BS; Celik C
    Arch Gynecol Obstet; 2015 Aug; 292(2):391-7. PubMed ID: 25608758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of the 2018 FIGO staging system for cervical cancer.
    Mohamud A; Høgdall C; Schnack T
    Gynecol Oncol; 2022 Jun; 165(3):506-513. PubMed ID: 35346512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens?
    Momeni M; Kolev V; Cardenas-Goicoechea J; Getrajdman J; Fishman D; Chuang L; Kalir T; Rahaman J; Zakashansky K
    Am J Obstet Gynecol; 2013 Jan; 208(1):71.e1-6. PubMed ID: 23099190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer.
    Gadducci A; Cavazzana A; Cosio S; DI Cristofano C; Tana R; Fanucchi A; Teti G; Cristofani R; Genazzani AR
    Anticancer Res; 2009 May; 29(5):1715-20. PubMed ID: 19443392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implication of new figo surgical staging on patterns of failure and survival in endometrial carcinoma.
    Park T; Mann W; Meek A; Bethune W; Chalas E; Kim J
    Int J Oncol; 1994 Jan; 4(1):247-53. PubMed ID: 21566920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.
    Narayan K; Khaw P; Bernshaw D; Mileshkin L; Kondalsamy-Chennakesavan S
    Int J Gynecol Cancer; 2012 Feb; 22(2):260-6. PubMed ID: 22080878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification.
    Werner HM; Trovik J; Marcickiewicz J; Tingulstad S; Staff AC; Amant F; Salvesen HB;
    Gynecol Oncol; 2012 Apr; 125(1):103-8. PubMed ID: 22100838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.